VRTX Vertex Pharmaceuticals
- Official Name: VERTEX PHARMACEUTICALS INCORPORATED
- Headquarters: 50 Northern Avenue, BOSTON, MA, 02210 US
- CEO: Reshma Kewalramani
- Website: vrtx.com
- Key Investor: CAPITAL WORLD INVESTORS | 11.11%
- Dedicated Investor: BRIDGER MANAGEMENT, LLC | 9.89%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Lost by 4.762 | 1.661 - 6.423 | ||
| 2025-07-22 | 2 | Lost by 7.742 | 1.322 - 9.064 | ||
| 2025-07-29 | 3 | Lost by 2.706 | (0.929) - 1.777 | ||
| 2025-07-29 | 2R | Won by 0.079 | 1.319 - 1.240 | ||
| 2025-08-05 | 4 | Lost by 14.199 | (15.489) - (1.290) | ||
| 2025-08-07 | 1R | Won by 0.352 | 0.085 - (0.267) | ||
| 2025-08-12 | 5 | Won by 18.363 TOTW | 18.488 - 0.125 | ||
| 2025-08-12 | 3R | Won by 0.429 | 3.315 - 2.886 | ||
| 2025-08-19 | 6 | Lost by 0.736 | 2.315 - 3.051 | ||
| 2025-08-21 | 2R | Won by 2.266 | 0.980 - (1.286) | ||
| 2025-08-26 | 7 | Lost by 3.826 | (0.897) - 2.929 | ||
| 2025-08-26 | 4R | Lost by 0.702 | (0.484) - 0.218 | ||
| 2025-09-02 | 8 | Won by 3.542 TOTW | 3.429 - (0.113) | ||
| 2025-09-03 | 1R | Lost by 0.314 | (1.096) - (0.782) | ||
| 2025-09-04 | 3R | Lost by 2.088 | 0.078 - 2.166 | ||
| 2025-09-09 | 9 | Lost by 1.837 | (1.144) - 0.693 | ||
| 2025-09-16 | 10 | Won by 1.462 | (1.714) - (3.176) | ||
| 2025-09-23 | 11 | Lost by 8.059 | (2.919) - 5.140 | ||
| 2025-09-30 | 12 | Won by 3.632 | 3.003 - (0.629) | ||
| 2025-10-07 | 13 | Won by 2.135 | 4.689 - 2.554 | ||
| 2025-10-14 | 14 | Lost by 0.458 | 0.475 - 0.933 | ||
| 2025-10-21 | 15 | Won by 4.126 | 3.442 - (0.684) |
Latest News
Yahoo - 2026-10-16
Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the st...
Yahoo - 2026-10-16
1 Nasdaq 100 Stock on Our Watchlist and 2 That Underwhelm
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenge...
CNBC - 2026-10-16
Sickle cell gene therapies offer new hope, but access remains a major challenge
FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.
Yahoo - 2026-10-15
Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts
Vertex Pharmaceuticals (VRTX) reached $508.75 at the closing of the latest trading day, reflecting a +2.06% change compared to its last close.
Yahoo - 2026-10-15
Vortex Energy Corp. Announces Extension of Marketing Program
VANCOUVER, British Columbia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company...
Yahoo - 2026-10-15
Forget Cystic Fibrosis: Vertex's Next Growth Engine Could Be Hormone Disorders
Vertex Pharmaceuticals is showing that it isn't a one-trick pony.
Yahoo - 2026-10-15
What You Need to Know Ahead of Vertex Pharmaceuticals’ Earnings Release
Vertex Pharmaceuticals is set to report its Q3 results next month, with analysts anticipating single-digit EPS growth alongside continued earnings gro...
Yahoo - 2026-10-14
3 Top Quality Value Stocks To Watch In October 2026
Rising gasoline and diesel costs are pushing US inflation higher, and that puts steady cash generation and conservative balance sheets back in the spo...
Yahoo - 2026-10-13
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine just cleared a key FDA h...
Yahoo - 2026-10-12
2 High-Flying Stocks on Our Watchlist and 1 We Question
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes j...
Show more
Yahoo - 2026-10-09
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
Yahoo - 2026-10-09
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference
Yahoo - 2026-10-09
Is Vertex Stock Worth More Than Its Competitors?
Benzinga - 2026-10-09
Vertex Presents Study Reporting ALYFTREK Data Shows Pancreatic Function Recovery In Some Children Ages 2–5 With Cystic Fibrosis
Benzinga - 2026-10-09
If You Invested $100 In Vertex Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today
Yahoo - 2026-10-08
Why Pacira BioSciences Stock Is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition
Benzinga - 2026-10-08
RBC Capital Maintains Outperform on Vertex Pharmaceuticals, Raises Price Target to $576
Yahoo - 2026-10-07
Vertex to Announce Third Quarter 2026 Financial Results November 2nd
Yahoo - 2026-10-07
NVIDIA And 2 Elite Undervalued Stocks To Own
Yahoo - 2026-10-06
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?
Benzinga - 2026-10-05
Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average
Yahoo - 2026-10-05
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Yahoo - 2026-10-05
Vortex Energy Commissions Hydrogen and Helium Study at Robinsons River Salt Project
Yahoo - 2026-10-05
2 Safe-and-Steady Stocks with Promising Prospects and 1 We Turn Down
Yahoo - 2026-10-01
Vertex Pharmaceuticals And 2 Other Top Gene Therapy Stocks
Yahoo - 2026-10-01
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Yahoo - 2026-10-01
Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
SeekingAlpha - 2026-09-30
The Top HealthTech Questions Landing On Our Desks
Benzinga - 2026-09-29
$100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
Benzinga - 2026-09-29
10 Health Care Stocks Whale Activity In Today’s Session
Yahoo - 2026-09-29
2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.
SeekingAlpha - 2026-09-29
Vertex Pharmaceuticals- Still Too Much Emphasis On CF Supremacy - I Foresee A Downgrade
SeekingAlpha - 2026-09-29
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
Yahoo - 2026-09-28
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
Benzinga - 2026-09-28
Alphabet To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga - 2026-09-28
UBS Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $615
Yahoo - 2026-09-28
2 Healthcare Stocks to Target This Week and 1 We Avoid
Yahoo - 2026-09-26
2 Healthcare Stocks That Just Delivered Great News for Investors
Yahoo - 2026-09-25
Maze Therapeutics (MAZE) Shares Moved, So What Is Driving Attention Now?
Yahoo - 2026-09-24
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know
SeekingAlpha - 2026-09-24
Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing
Yahoo - 2026-09-24
Will Vertex's Kidney Disease Pipeline Be a New Growth Engine?
Yahoo - 2026-09-24
Lilly’s latest China drug deal; Immunovant’s setback in lupus
Yahoo - 2026-09-24
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo - 2026-09-23
Vertex Posts Positive Phase II Data on Kidney Disease Drug
Yahoo - 2026-09-23
Maze Therapeutics Shares Rise 2.9% After CIBC Initiates Coverage
Yahoo - 2026-09-23
CRISPR Therapeutics Traded Sideways and Down for 12 Months: One Wall Street Pro Expects 85% Gains Soon
Yahoo - 2026-09-22
The Surprise That Sent Vertex — And Its Chief Rival — Soaring
Yahoo - 2026-09-22
Vertex’s Kidney Drug Success Sparks a 22% Surge for This Rival Biotech
SeekingAlpha - 2026-09-22
SBIO: Big Pharma Needs What This Fund Owns
Yahoo - 2026-09-22
ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know
Benzinga - 2026-09-22
Vertex Touts Encouraging Data From 'Underappreciated' Kidney Drug
Yahoo - 2026-09-22
Chronic Kidney Disease (CKD) Market Gains Momentum as Pipeline Innovation and Clinical Trials Reshape the Competitive Landscape in 2026
Yahoo - 2026-09-22
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo - 2026-09-18
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
Yahoo - 2026-09-18
2 Reasons to Like VRTX (and 1 Not So Much)
Yahoo - 2026-09-18
Is This Biotech Stock Too Cheap to Ignore After Its Latest Pullback?
Yahoo - 2026-09-17
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?
Yahoo - 2026-09-17
Vortex Energy Enters Into Asset Purchase Agreement to Acquire the Meadows Project in Saskatchewan
Yahoo - 2026-09-17
Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
Yahoo - 2026-09-16
SION to Cut Workforce by Nearly Half After CF Study Failure, Stock Down
Yahoo - 2026-09-15
Will Vertex’s (VRTX) New CFO Elevation and Digital Focus Reframe Its Capital Allocation Narrative?
Yahoo - 2026-09-15
Vertex Pharmaceuticals (VRTX), Why Is It Getting Fresh Attention Now?
Yahoo - 2026-09-15
Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial Results
SeekingAlpha - 2026-09-15
Undercovered Dozen: Ares Capital, Grab, Lenovo, Rigetti And More
Yahoo - 2026-09-14
1 Unpopular Stock That Should Get More Attention and 2 We Brush Off
Yahoo - 2026-09-14
Vortex Energy Engages Lonquist to Manage Ground Gravity Survey at the Robinsons River Salt Project
SeekingAlpha - 2026-09-14
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Yahoo - 2026-09-12
Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference
Yahoo - 2026-09-11
Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis
Yahoo - 2026-09-11
Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher
SeekingAlpha - 2026-09-10
Vertex Pharmaceuticals Incorporated (VRTX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
SeekingAlpha - 2026-09-10
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
SeekingAlpha - 2026-09-09
Vertex Pharmaceuticals: Solid Growth But Valuation Still Requires Flawless Execution
Yahoo - 2026-09-08
Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock
Yahoo - 2026-09-08
Vertex Pharmaceuticals (VRTX) Suffers a Larger Drop Than the General Market: Key Insights
Yahoo - 2026-09-08
Why CRISPR Therapeutics Stock Rocked the Market Last Month
Yahoo - 2026-09-08
3 Market-Beating Stocks for Long-Term Investors
Yahoo - 2026-09-08
Where Will CRISPR Therapeutics Stock Be in 5 Years?
Yahoo - 2026-09-08
Register Now: Limited Seating Remains for HMG Strategy’s Sept. 10 Boston C-Level Technology Leadership Summit
Yahoo - 2026-09-08
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Yahoo - 2026-09-07
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party?
SeekingAlpha - 2026-09-05
CRISPR Therapeutics: CASGEVY Validates The Platform, Strengthening The Acquisition Case
Yahoo - 2026-09-04
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
Benzinga - 2026-09-04
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today
Yahoo - 2026-09-03
Vortex Energy Announces Plans for Ground Gravity Survey at the Robinsons River Salt Project
SeekingAlpha - 2026-09-03
The Market May Be Telling Us We're Entering A Capital Formation Cycle
Yahoo - 2026-09-02
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
Yahoo - 2026-09-02
How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?
Benzinga - 2026-09-02
Morgan Stanley Reinstates Overweight on Vertex Pharmaceuticals, Announces $665 Price Target
Yahoo - 2026-09-01
Vertex (VRTX) Stock Trades At A Premium On Earnings Yet Looks Fair On Broader Checks
Yahoo - 2026-09-01
Goldman Sachs refreshes conviction lists on both sides of the Atlantic
Yahoo - 2026-09-01
Vertex Pharmaceuticals (VRTX) Could Be 3% Undervalued If Its Pipeline Growth Holds
Yahoo - 2026-09-01
Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform
Yahoo - 2026-09-01
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
Yahoo - 2026-09-01
OncoC4 Appoints Dr. Steve Chen, JD, PhD as General Counsel
Yahoo - 2026-08-31
1 S&P 500 Stock with Exciting Potential and 2 We Ignore
Yahoo - 2026-08-31
Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?
SeekingAlpha - 2026-08-31
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
Benzinga - 2026-08-27
If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
Yahoo - 2026-08-26
Vertex to Participate in Upcoming September Investor Conferences
Yahoo - 2026-08-26
Vertex Pharmaceuticals Up 15% in a Month: How to Play the Stock
Yahoo - 2026-08-26
2 Large-Cap Stocks to Research Further and 1 We Question
Yahoo - 2026-08-24
Inflation Is Rising Again. History Says These 2 Stocks Are Among the Smartest Places to Hide
Benzinga - 2026-08-21
Uber, ServiceNow And A Health Care Stock On CNBC’s ‘Final Trades’
Yahoo - 2026-08-20
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Yahoo - 2026-08-20
Are Wall Street Analysts Bullish on Vertex Stock?
Yahoo - 2026-08-19
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
Yahoo - 2026-08-18
Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project
Yahoo - 2026-08-18
3 Cash-Producing Stocks on Our Watchlist
Yahoo - 2026-08-14
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
Yahoo - 2026-08-14
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
Yahoo - 2026-08-14
Vertex Pharmaceuticals (VRTX) Could Be 8% Undervalued Following Raised 2026 Guidance
Yahoo - 2026-08-14
BofA biotech scorecard: Two buys and odd one out
Benzinga - 2026-08-14
$100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
SeekingAlpha - 2026-08-14
Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)
Yahoo - 2026-08-13
Inside Latigo Biotherapeutics’ IPO: A Non-Opioid Pain Bet Goes Public
Yahoo - 2026-08-11
One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet Collapses
Yahoo - 2026-08-11
4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year
Yahoo - 2026-08-10
Vertex (VRTX) Q2 2026 Earnings Call Transcript
ChartMill - 2026-08-10
Discover which S&P500 stocks are making waves on Monday.
Yahoo - 2026-08-10
SION Stock On Track For Worst Day Ever After 90% Drop — What’s Driving The Selloff?
ChartMill - 2026-08-10
Explore the top gainers and losers within the S&P500 index in today's session.
Yahoo - 2026-08-10
Why Sionna Therapeutics Stock Is Crashing 92% to a Record Low
Yahoo - 2026-08-10
Vertex Stock Jumps 5.9% as Rival Cystic Fibrosis Drug Fails
Yahoo - 2026-08-10
Vertex Pharmaceuticals (VRTX) Is Up 5.4% After Raising 2026 Revenue Guidance And Expanding Its Pipeline - Has The Bull Case Changed?
Yahoo - 2026-08-10
Why Vertex Pharma Popped, As A Key Rival Plummeted 90%
ChartMill - 2026-08-10
Get insights into the top movers in the S&P500 index of Monday's pre-market session.
Yahoo - 2026-08-10
Sionna cystic fibrosis drug fails key trial, removing threat to Vertex
SeekingAlpha - 2026-08-08
Tracking Tweedy Browne Portfolio - Q2 2026 Update
Yahoo - 2026-08-07
What Insmed Stock's Premium Is Actually Buying
Yahoo - 2026-08-06
IONQ Q2 Earnings Miss Estimates, Revenues Beat, Stock Rises
Yahoo - 2026-08-06
Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt Project
Yahoo - 2026-08-06
AbCellera Biologics Inc (ABCL) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress and ...
Yahoo - 2026-08-05
AbCellera Biologics Q2 Earnings Call Highlights
Benzinga - 2026-08-05
Truist Securities Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $565
Yahoo - 2026-08-05
Entrada Therapeutics Reports Second Quarter 2026 Financial Results
SeekingAlpha - 2026-08-05
CRISPR: "Strong Buy" CASGEVY Sales Growth And In Vivo Expansion With CTX310
Benzinga - 2026-08-05
Barclays Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $617
Yahoo - 2026-08-04
Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says
Yahoo - 2026-08-04
How Vertex Regained Its Footing On A Competitor's Bullish Report
Yahoo - 2026-08-04
VRTX's Q2 Earnings Lag Estimates, Revenues Top, 2026 Sales View Raised
Yahoo - 2026-08-04
CRISPR Therapeutics' Q2 Earnings & Revenues Surpass Estimates
Yahoo - 2026-08-04
VRTX Q2 Earnings Call Highlights Launch Momentum & Higher Outlook
Yahoo - 2026-08-04
Vertex Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary
Benzinga - 2026-08-04
TD Cowen Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $550
Yahoo - 2026-08-04
Vertex’s biggest overhang: a rival 50 times smaller
Yahoo - 2026-08-04
Vertex (VRTX) Buys Crinetics To Push Beyond Cystic Fibrosis
Yahoo - 2026-08-04
Crinetics Pharmaceuticals (CRNX) Stock Looks Pricey As Buyout News Lands
Benzinga - 2026-08-04
Cantor Fitzgerald Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $595
SeekingAlpha - 2026-08-04
Vertex Pharmaceuticals: A Transition Year Into A Multi-Franchise Growth Story
Yahoo - 2026-08-04
Vertex Pharmaceuticals Inc (VRTX) (Q2 2026) Earnings Call Highlights: Revenue Surges 12% to $3. ...
SeekingAlpha - 2026-08-03
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-03
Vertex Pharmaceuticals Q2 Earnings Call Highlights
SeekingAlpha - 2026-08-03
Vertex Pharmaceuticals Incorporated 2026 Q2 - Results - Earnings Call Presentation
Yahoo - 2026-08-03
Vertex (VRTX) Reports Q2 Earnings: What Key Metrics Have to Say
Yahoo - 2026-08-03
Vertex Pharmaceuticals (VRTX) Q2 Earnings Lag Estimates
Yahoo - 2026-08-03
Vertex Raises 2026 Guidance, But Shares Dip For One Key Reason
Yahoo - 2026-08-03
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations
Yahoo - 2026-08-03
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo - 2026-08-03
Vertex Reports Second Quarter 2026 Financial Results
Benzinga - 2026-08-03
Vertex Pharmaceuticals Raises FY2026 Sales Guidance from $12.950B-$13.100B to $13.100B-$13.200B vs $13.065B Est
Benzinga - 2026-08-03
Vertex Pharmaceuticals Q2 Adj. EPS $4.73, Inline, Sales $3.334B Beat $3.232B Estimate
SeekingAlpha - 2026-08-03
Divided Tech, Divided Fed: Navigating AI Capex Scrutiny And Mixed Macro Signals
Yahoo - 2026-08-03
Falling Oil Boosts Wall Street Pre-Bell; Asia Mixed, Europe Up
Benzinga - 2026-08-02
Tyson Foods, Marriott And 3 Stocks To Watch Heading Into Monday
Benzinga - 2026-08-02
Nasdaq Jumps 1% as Amazon Shares Surge: Investor Sentiment Improves, But Greed Index Remains in 'Fear' Zone
Yahoo - 2026-07-31
Is The Recent Pullback In Alnylam Stock An Opportunity Or A Trap?
Yahoo - 2026-07-30
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target
Yahoo - 2026-07-29
Vertex Pharmaceuticals (VRTX) Expands Its Pipeline Reach, Is The Stock Fully Valued?
Yahoo - 2026-07-29
Vertex Pharmaceuticals (VRTX) Stock Looks Like A Bargain At This Price
Yahoo - 2026-07-29
Vertex (VRTX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Yahoo - 2026-07-29
AbCellera, Vertex partner on next-gen T-cell engagers
Yahoo - 2026-07-29
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
ChartMill - 2026-07-29
Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth and Textbooks Technical Setup for Breakout
Yahoo - 2026-07-28
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
CNBC - 2026-07-28
Chris Young, Vertex CEO: A Fortt Knox Conversation
Yahoo - 2026-07-27
Vertex Gears Up to Report Q2 Earnings: What Can Investors Expect?
Yahoo - 2026-07-27
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Yahoo - 2026-07-24
Vortex Energy Corp. Announces Marketing Program
Yahoo - 2026-07-23
Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company?
Yahoo - 2026-07-23
3 Healthcare Stocks with Competitive Advantages
Yahoo - 2026-07-22
Vertex Pharmaceuticals (VRTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Yahoo - 2026-07-22
Vertex was sole bidder in high-premium Crinetics acquisition
Benzinga - 2026-07-21
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
Yahoo - 2026-07-21
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
Yahoo - 2026-07-21
Biotech IPO Gains Crush AI Listings With Standout 55% Return
ChartMill - 2026-07-21
Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation
Yahoo - 2026-07-20
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today
Yahoo - 2026-07-20
How FDA’s Pediatric Expansion of Casgevy at Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story
Yahoo - 2026-07-16
1 Nasdaq 100 Stock to Keep an Eye On and 2 We Question
Yahoo - 2026-07-16
Collect 9.8% On VRTX Stock Now, And Still Keep 15% Of Upside
Yahoo - 2026-07-16
Vortex Energy Provides Corporate Update on Robinsons River Salt Project Technical Study
SeekingAlpha - 2026-07-16
The Battle For Sickle Cell
Benzinga - 2026-07-15
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Yahoo - 2026-07-15
IBB ETF Holds Fewer Bets Than You Think
Yahoo - 2026-07-14
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals
Yahoo - 2026-07-13
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
Yahoo - 2026-07-13
Vortex Energy Corp. Announces Closing of LIFE Offering
Yahoo - 2026-07-13
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
Benzinga - 2026-07-13
UBS Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $585
Benzinga - 2026-07-13
Truist Securities Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $560
Yahoo - 2026-07-11
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
Yahoo - 2026-07-10
Is This Biotech Stock a Buy Near Its 52-Week High?
Yahoo - 2026-07-10
Why This Pharmaceutical Stock Jumped Close to 100% This Week
Yahoo - 2026-07-10
If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago, This is How Much It'd Be Worth Now
Yahoo - 2026-07-10
The Long Climb Back For Ionis Stock
Yahoo - 2026-07-10
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?
Yahoo - 2026-07-09
Vertex (VRTX) is One of the Best QQQ Stocks to Invest in
Yahoo - 2026-07-09
Why Crinetics Stock Soared 99% This Week
Yahoo - 2026-07-09
Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
Yahoo - 2026-07-09
Cystic Fibrosis Market, Global & Regional Now Available; Profiles Vertex Pharmaceuticals, AbbVie, and Other Frontrunner Competitors in Orphan Drug Markets
Yahoo - 2026-07-09
1 Momentum Stock to Research Further and 2 Facing Headwinds
Benzinga - 2026-07-09